Long-term Survival and Value of CAR T-Cell Therapy for Pediatric Patients with Relapsed or Refractory Leukemia; Assessment of Exposure to High-Performing Schools and Risk of Adolescent Substance Use
JAMA Pediatrics Editors' Summary3 Dec 2018

Long-term Survival and Value of CAR T-Cell Therapy for Pediatric Patients with Relapsed or Refractory Leukemia; Assessment of Exposure to High-Performing Schools and Risk of Adolescent Substance Use

JAMA Pediatrics Editors' Summary by Dimitri Christakis, MD, MPH, Editor in Chief, and Frederick Rivara, MD, MPH, Editor of JAMA Network Open, for the December 3, 2018 issue

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
paranormalt-med-caroline-giertz
svd-nyhetsartiklar
allt-du-velat-veta
rss-vetenskapligt-talat
kapitalet-en-podd-om-ekonomi
rss-vetenskapspodden
dumforklarat
rss-vetenskapsradion
rss-ufobortom-rimligt-tvivel
rss-vetenskapsradion-2
sexet
rss-i-hjarnan-pa-louise-epstein
medicinvetarna
det-morka-psyket
rss-spraket
vetenskapsradion
a-kursen
hacka-livet